CoChat

Proton pump inhibitor therapy predisposes to community‐acquired Streptococcus pneumoniae pneumonia

de Jager, C. P. C., Wever, P. C., Gemen, E. F. A., van Oijen, M. G. H., van Gageldonk‐Lafeber, A. B., Siersema, P. D., Kusters, G. C. M., Laheij, R. J. F. · 2012 · Alimentary Pharmacology & Therapeutics
Cited by 76

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Background: The pathophysiological mechanisms which contribute to an increased risk of community‐acquired pneumonia (CAP) in patients using proton pump inhibitors are not well established. Aim: To examine differences in microbial etiology in patients with CAP between patients with and without proton pump inhibitor (PPI) therapy and its possible impact on disease severity. Methods: All individuals consulting the emergency care unit were prospectively registered and underwent chest radiography. Sputum, urine, nose‐throat swabs and blood samples were obtained for microbial evaluation. We evaluated the association between use of proton pump inhibitors, etiology of CAP and severity of illness with multivariate regression analysis. Results: The final cohort comprised 463 patients, 29% using proton pump inhibitors (PPI s). Pathogens regarded as oropharyngeal flora were more common in CAP patients using PPI therapy compared to those who did not (adjusted OR: 2.0; 95% CI: 1.22–3.72). Patients using proton pump inhibitors more frequently had an infection with S treptococcus pneumoniae (28% vs. 14%) and less frequently with C oxiella burnetii (8% vs. 19%) compared to nonuser of PPI. Adjusted for baseline differences, the risk of PPI users being infected with S. pneumonia was 2.23 times (95% CI: 1.28–3.75) higher compared to patients without PPI's. No risk between PPI use and any other microbial pathogen was found. There was no difference in severity of CAP between patients with and without using PPI therapy. Conclusions: Proton pump inhibitor therapy was associated with an approximately 2‐fold increased risk to develop community‐acquired pneumonia possibly as a result of S. pneumoniae infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.12069

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 76

Metadata

Authors
de Jager, C. P. C., Wever, P. C., Gemen, E. F. A., van Oijen, M. G. H., van Gageldonk‐Lafeber, A. B., Siersema, P. D., Kusters, G. C. M., & Laheij, R. J. F.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2012-10-03
Volume
36
Issue
10
Pages
941-949
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2170074113
Cited by
76
References
3
FWCI
5.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proton pump inhibitor therapy predisposes to community‐acquired Streptococcus pneumoniae pneumonia. https://app.cochat.ai/papers/10.1111/apt.12069
The paper
de Jager, C. P. C., Wever, P. C., Gemen, E. F. A., van Oijen, M. G. H., van Gageldonk‐Lafeber, A. B., Siersema, P. D., Kusters, G. C. M., & Laheij, R. J. F. (2012). Proton pump inhibitor therapy predisposes to community‐acquired Streptococcus pneumoniae pneumonia. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.12069

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.